Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

1081 - 1090 of 3488 results found

Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. S2k-LL (DGN)

MeSH Terms

Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
First epileptic seizure and epilepsy in adulthood
Keywords
Epilepsie, erster epileptischer Anfall, Anfallssuppressiva, Epilepsiechirurgie, Komorbidität, psychosoziale Aspekte, Epilepsy, first epileptic seizure, antiseizure medication, epilepsy surgery, co-morbidity, psychosocial aspects
Date for Review
31/08/2028
Publication Date
14/09/2023
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2023

Ersttrimester Diagnostik und Therapie @ 11-13+6 Schwangerschaftswochen. S2e-LL (DEGUM)

MeSH Terms

Pregnancy (G08.686.785.760.769)

Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
First Trimester Diagnostics and Therapy @ 11-13 + 6 weeks gestation
Keywords
Ersttrimester Screening, Nackentransparenz, Risikoberechnung, Trisomie, Algorithmus, first trimester screening, nuchal translucency, risk assessment, trisomy, algorithm
Date for Review
31/12/2028
Publication Date
05/01/2024
Publication Scope
assessment
counselling
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AWMF (DE)
Publication Year
2024

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Agents Targeting Lymphoid Cells Surface Antigens [I]: CD19, CD20 and CD52)

MeSH Terms
Biological Therapy (E02.095); Infectious Disease Medicine (H02.403.429.480)
Guideline Contact
Chiara Speziale (guidancedocuments@escmid.org)
Publication Scope
treatment
Guideline Publication Status
Published
Languages
English
Authors
ESCMID
Publication Year
2018

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)

MeSH Terms
Biological Therapy (E02.095); Infectious Disease Medicine (H02.403.429.480)
Guideline Contact
Chiara Speziale (guidancedocuments@escmid.org)
Publication Scope
treatment
Guideline Publication Status
Published
Languages
English
Authors
ESCMID
Publication Year
2018

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Intracellular Signaling Pathways: Tyrosine Kinase and mTOR Inhibitors)

MeSH Terms
Biological Therapy (E02.095); Protein-Tyrosine Kinases (D08.811.913.696.620.682.725); Receptor Protein-Tyrosine Kinases (D08.811.913.696.620.682.725.400); Receptor Protein-Tyrosine Kinases (D12.776.543.750.060); Infectious Disease Medicine (H02.403.429.480)
Guideline Contact
Chiara Speziale (guidancedocuments@escmid.org)
Publication Scope
treatment
Guideline Publication Status
Published
Languages
English
Authors
ESCMID
Publication Year
2018

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the Safety of Targeted and Biological Therapies: An Infectious Diseases Perspective (Soluble Immune Effector Molecules [I]: Anti-Tumor Necrosis Factor-α Agents)

MeSH Terms
Biological Therapy (E02.095); Infectious Disease Medicine (H02.403.429.480); Tumor Necrosis Factor-alpha (D23.529.374.500.800); Tumor Necrosis Factor-alpha (D12.776.467.374.750.626); Tumor Necrosis Factor-alpha (D12.644.276.374.750.626); Tumor Necrosis Factor-alpha (D23.529.374.750.626); Tumor Necrosis Factor-alpha (D12.776.467.972.626); Tumor Necrosis Factor-alpha (D12.644.276.972.626); Tumor Necrosis Factor-alpha (D23.529.972.626)
Guideline Contact
Chiara Speziale (guidancedocuments@escmid.org)
Publication Scope
treatment
Guideline Publication Status
Published
Languages
English
Authors
ESCMID
Publication Year
2018